Skip to content
★ Sign in to follow
MF
Total declarations
3
Company
1
▲ Purchases (3 ops.)
€83k
▼ Sales (0 ops.)
—

Latest filing published 06 Dec 2019 for Astrana Health, Inc., €32k.

Filing timeline

BuySale
Michael F. Eng

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3
Positive at T+90
33%
Median T+90
-5.4%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 06 Dec 2019 · 2530 days ago · €32k
    +6.3%
    Entry US$16.83 · Close at T+365 US$17.89
  • Filed 16 Sept 2019 · 2611 days ago · €37k
    -16.7%
    Entry US$20.78 · Close at T+365 US$17.30
  • Filed 20 Aug 2019 · 2638 days ago · €14k
    +8.4%
    Entry US$15.78 · Close at T+365 US$17.10

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Michael F. Eng: trading record in brief

Michael F. Eng appears in our data through filings on Astrana Health, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 19 August 2019 to 4 December 2019, the count stands at 3 filings.

The open-market record is one-sided, with 3 purchases worth €83k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

A typical purchase (the median) is worth €32k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 33% of cases, with a median move of -5.4%. This is a record of the past, not a forecast.

The record was last updated on 6 December 2019 with an open-market purchase (€32k) in Astrana Health, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Michael F. Eng

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    DirectorExecutivesAstrana Health, Inc.
    34,927 USD37SEC
    1,890 shares@ US$18.4838.1% of flowCommon StockSEC:0001104659-19-070571:0
    Canonical exit: 3 Mar 2020 (T+90)
  • ▲
    DirectorExecutivesAstrana Health, Inc.
    40,560 USD35SEC
    2,000 shares@ US$20.2844.4% of flowCommon StockSEC:0001144204-19-044784:0
    Canonical exit: 11 Dec 2019 (T+90)
  • ▲
    DirectorExecutivesAstrana Health, Inc.
    15,970 USD31SEC
    1,000 shares@ US$15.9717.4% of flowCommon StockSEC:0001553350-19-000873:0
    Canonical exit: 17 Nov 2019 (T+90)

3 of 3 declarations